nach oben

Erschienen in:

01.03.2024 | Research

Supplement use and its impact on daily life of cancer patients: a cross-sectional study

verfasst von: Youssef El Toum, Tarek Costa, Elissa El Toum, Tina Haddad, Pascale Salameh, Fady El karak, Marwan Ghosn, Fady Nasr, Georges Chahine, Joseph Kattan, Hampig Raphael Kourie

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This cross-sectional study aimed to investigate the prevalence and characteristics of supplement usage among cancer patients and explore its potential associations with anxiety, excessive daytime sleepiness, and overall quality of life.

Methods

Cancer patients receiving specific care at Hôtel Dieu de France University Hospital, Beirut, were enrolled between April and June 2023. In face-to-face interviews, participants were asked to complete a questionnaire consisting of sociodemographic information, supplement usage details, and cancer-related variables. Three validated surveys (Epworth Sleepiness Scale, GAD-7, and EORTC-QLQ-C15-PAL) were employed to assess excessive daytime sleepiness, anxiety, and overall quality of life. Statistical analyses, including chi-square tests, t-tests, and multiple regression models, were conducted to examine associations between supplement use and other variables.

Results

A total of 202 participants were interviewed. Fifty-two percent reported regular use of supplements following their cancer diagnosis, with vitamin D being the most commonly used supplement. Using multivariate logistic regression, supplement use was associated with being female, having lower educational levels, having a longer duration since cancer diagnosis, and having a poor overall quality of life. The multivariate logistic regression showed no significant correlation between supplement use and excessive daytime sleepiness and anxiety.

Conclusion

This study highlights a high prevalence of supplement usage among cancer patients in Lebanon, indicating a rising interest in alternative therapies aimed at enhancing quality of life. Larger prospective studies are needed to assess the relation between supplement intake and excessive daytime sleepiness and anxiety and establish clear guidelines pertaining to supplement use in cancer patients.

Dietary supplements. American Cancer Society (n.d.) https://www.cancer.org/cancer/managing-cancer/treatment-types/complementary-and-integrative-medicine/dietary-supplements.html

Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11(3):187–203. https://doi.org/10.1177/1534735411423920CrossRefPubMed

Du M, Luo H, Blumberg JB, Rogers G, Chen F, Ruan M, Shan Z, Biever E, Zhang FF (2020) Dietary supplement use among adult cancer survivors in the United States. J Nutr 150(6):1499–1508. https://doi.org/10.1093/jn/nxaa040CrossRefPubMedPubMedCentral

Naja F, Anouti B, Shatila H, Akel R, Haibe Y, Tfayli A (2017) Prevalence and correlates of complementary and alternative medicine use among patients with lung cancer: a cross-sectional study in Beirut, Lebanon. Evid-Based Complement Altern Med: eCAM 2017:8434697. https://doi.org/10.1155/2017/8434697CrossRef

Naja F, Fadel RA, Alameddine M, Aridi Y, Zarif A, Hariri D, Mugharbel A, Khalil M, Nahleh Z, Tfayli A (2015) Complementary and alternative medicine use and its association with quality of life among Lebanese breast cancer patients: a cross-sectional study. BMC Complement Altern Med 15:444. https://doi.org/10.1186/s12906-015-0969-9CrossRefPubMedPubMedCentral

Bailey RL et al (2011) Dietary supplement use in the United States, 2003–2006. J Nutr 141:261–266. https://doi.org/10.3945/jn.110.133025CrossRefPubMed

Li K, Kaaks R, Linseisen J, Rohrmann S (2010) Consistency of vitamin and/or mineral supplement use and demographic, lifestyle and health-status predictors: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heidelberg cohort. Br J Nutr 104:1058–1064. https://doi.org/10.1017/S0007114510001728CrossRefPubMed

Clinton SK, Giovannucci EL, Hursting SD (2020) The World Cancer Research Fund/American Institute for Cancer Research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J Nutr 150(4):663–671. https://doi.org/10.1093/jn/nxz268CrossRefPubMed

U.S. Department of Health and Human Services (2021) Cancer and complementary health approaches: what you need to know. National Center for Complementary and Integrative Health. https://www.nccih.nih.gov/health/cancer-and-complementary-health-approaches-what-you-need-to-know. Accessed 2021

10.

Sohl SJ, Weaver KE, Birdee G, Kent EE, Danhauer SC, Hamilton AS (2014) Characteristics associated with the use of complementary health approaches among long-term cancer survivors. Support Care Cancer 22(4):927–936. https://doi.org/10.1007/s00520-013-2040-zCrossRefPubMed

11.

Tank M, Franz K, Cereda E, Norman K (2021) Dietary supplement use in ambulatory cancer patients: a survey on prevalence, motivation, and attitudes. J Cancer Res Clin Oncol 147(7):1917–1925. https://doi.org/10.1007/s00432-021-03594-7CrossRefPubMedPubMedCentral

12.

Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12(2):160–174. https://doi.org/10.1016/S1470-2045(11)70002-XCrossRefPubMed

13.

Lee HR, Song YM, Jeon KH, Cho IY (2021) The association between the use of dietary supplement and psychological status of cancer survivors in Korea: a cross-sectional study. Korean J Fam Med 42(4):317–326. https://doi.org/10.4082/kjfm.20.0184CrossRefPubMedPubMedCentral

14.

Saini A, Berruti A, Capogna S, Negro M, Sguazzotti E, Picci RL, Campagna S, Dongiovanni V, Dogliotti L, Furlan PM, Ostacoli L (2011) Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features. Qual Life Res 20(5):683–690. https://doi.org/10.1007/s11136-010-9795-1CrossRefPubMed

15.

Lis CG, Cambron JA, Grutsch JF, Granick J, Gupta D (2006) Self-reported quality of life in users and nonusers of dietary supplements in cancer. Support Care Cancer 14(2):193–199. https://doi.org/10.1007/s00520-005-0876-6CrossRefPubMed

16.

Büttner-Teleagă A, Kim YT, Osel T, Richter K (2021) Sleep disorders in cancer-a systematic review. Int J Environ Res Public Health 18(21):11696. https://doi.org/10.3390/ijerph182111696CrossRefPubMedPubMedCentral

17.

Spitzer RL, Kroenke K, Williams JB, Löwe B (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166(10):1092–1097. https://doi.org/10.1001/archinte.166.10.1092CrossRefPubMed

18.

Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14(6):540–545. https://doi.org/10.1093/sleep/14.6.540CrossRefPubMed

19.

Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hammerlid E, Kaasa S, Sprangers MA, Bjorner JB, EORTC Quality of Life Group (2006) The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42(1):55–64. https://doi.org/10.1016/j.ejca.2005.06.022

20.

Bauml J, Langer CJ, Evans T, Garland SN, Desai K, Mao JJ (2014) Does perceived control predict complementary and alternative medicine (CAM) use among patients with lung cancer? A cross-sectional survey. Support Care Cancer 22(9):2465–2472. https://doi.org/10.1007/s00520-014-2220-5CrossRefPubMedPubMedCentral

21.

Akpınar Ş, Karadağ MG (2022) Is vitamin D important in anxiety or depression? What is the truth? Curr Nutr Rep 11(4):675–681. https://doi.org/10.1007/s13668-022-00441-0CrossRefPubMedPubMedCentral

22.

Ferrucci LM, McCorkle R, Smith T, Stein KD, Cartmel B (2009) Factors related to the use of dietary supplements by cancer survivors. J Altern Complement Med 15(6):673–680. https://doi.org/10.1089/acm.2008.0387CrossRefPubMedPubMedCentral

23.

Verhoef MJ, Rose MS, White M, Balneaves LG (2008) Declining conventional cancer treatment and using complementary and alternative medicine: a problem or a challenge? Curr Oncol 15 Suppl 2(Suppl 2):s101–s106. https://doi.org/10.3747/co.v15i0.281

24.

Asif A, Farooq N (2023) Vitamin D toxicity. StatPearls Publishing, In StatPearls

25.

Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, Kelly KM, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Budd GT, Albain KS (2020) Dietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a cooperative group clinical trial (SWOG S0221). J Clin Oncol 38(8):804–814. https://doi.org/10.1200/JCO.19.01203CrossRefPubMed

26.

Vollbracht C, Schneider B, Leendert V, Weiss G, Auerbach L, Beuth J (2011) Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. In vivo (Athens, Greece) 25(6):983–990PubMed

27.

Magrì A, Germano G, Lorenzato A, Lamba S, Chilà R, Montone M, Amodio V, Ceruti T, Sassi F, Arena S, Abrignani S, D’Incalci M, Zucchetti M, Di Nicolantonio F, Bardelli A (2020) High-dose vitamin C enhances cancer immunotherapy. Sci Transl Med 12(532):eaay8707. https://doi.org/10.1126/scitranslmed.aay8707CrossRefPubMed

28.

Andersen MR, Sweet E, Hager S, Gaul M, Dowd F, Standish LJ (2019) Effects of vitamin D use on health-related quality of life of breast cancer patients in early survivorship. Integr Cancer Ther 18:1534735418822056. https://doi.org/10.1177/1534735418822056CrossRefPubMedPubMedCentral

29.

Liu J, Dong Y, Lu C, Wang Y, Peng L, Jiang M, Tang Y, Zhao Q (2017) Meta-analysis of the correlation between vitamin D and lung cancer risk and outcomes. Oncotarget 8(46):81040–81051. https://doi.org/10.18632/oncotarget.18766CrossRefPubMedPubMedCentral

Titel: Supplement use and its impact on daily life of cancer patients: a cross-sectional study
verfasst von: Youssef El Toum
Tarek Costa
Elissa El Toum
Tina Haddad
Pascale Salameh
Fady El karak
Marwan Ghosn
Fady Nasr
Georges Chahine
Joseph Kattan
Hampig Raphael Kourie
Publikationsdatum: 01.03.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 3/2024
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-024-08380-y

Springer Medizin

Supplement use and its impact on daily life of cancer patients: a cross-sectional study